Procaps Group Reports First Quarter 2023 Results
June 05, 2023 19:45 ET
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, June 05, 2023 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps”), a leading integrated international healthcare and pharmaceutical services company,...
Financial Results and Business Update Conference Call to be Held May 2023 in Conjunction with 20-F Filing
May 01, 2023 08:17 ET
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, May 01, 2023 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...
Procaps Issues Shareholder Letter and Provides Preliminary Fiscal Year 2022 Financial Results and 2023 Guidance
February 13, 2023 16:36 ET
|
Procaps Group, S.A.
Reports Preliminary Financial Estimates for Net Revenue and Adjusted EBITDA for Full Year 2022 Realigns Board of Directors to Focus on Profitable Growth Announces $5M+ Share Repurchase Program ...
Procaps Announces Key Changes to the Board of Directors
January 19, 2023 16:32 ET
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...
Procaps Group Announces Termination of Acquisition Agreement with Grupo Somar
January 03, 2023 16:13 ET
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...
Procaps to Present at 2023 Annual J.P. Morgan Healthcare Conference
December 29, 2022 08:00 ET
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...
Update on Proposed Acquisition of Grupo Somar
December 22, 2022 16:02 ET
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colo., Dec. 22, 2022 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...
Procaps Group Reports Third Quarter and Nine Months 2022 Results
November 14, 2022 17:32 ET
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Procaps Group S.A. (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today...
Procaps Group to Report Third Quarter and Nine Months of 2022 on November 14, 2022
November 08, 2022 15:36 ET
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced that it...
Procaps Announces ESG Commitments and Initiatives with Inaugural Report
October 11, 2022 08:00 ET
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced...